Assaying cellular markers for the evaluation of tumors
View Patent ↗An improved system for assaying expression of various markers, factors or antigens on the cultured cells for diagnostic purposes and for using such expression to monitor the applicability of certain candidate therapeutic or chemotherapeutic agents and the progress of treatment with those agents.
1. A method for evaluating a tumor for cancer state or cancer progression comprising the steps of:
mechanically separating a patient's tumor tissue specimen into multicellular tissue explants, wherein the explants are not dissociated cell suspensions, and the explants comprise malignant cells and stromal cells;
growing a tissue culture monolayer(s) from said explants in culture medium; and
assaying cells of said monolayer by immunohistochemistry to identify one or more membrane-bound markers indicative of cancer state or cancer progression, thereby evaluating the tumor for cancer state or cancer progression.
2. The method of claim 1 , wherein a profile of said membrane bound markers is determined.
3. The method of claim 1 , wherein the multicellular tissue explants have smooth cut edges.
4. The method of claim 3 , wherein said smooth cut edges are created by systematic mincing in a scissor-like motion.
5. The method of claim 1 , wherein the multicellular tissue explants have a size distribution of about 0.25 mm 3 to about 1.4 mm 3 .
6. The method of claim 5 , wherein the multicellular tissue explants have a size of about 1 mm 3 .
7. The method of claim 1 , wherein the tumor tissue specimen is selected from the group consisting of renal carcinoma, breast cancer, mesothelioma and ovarian tumor.